This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by DiTraglia, J. Search for Related Content PubMed PubMed Citation Articles by DiTraglia, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Attention Deficit Hyperactivity Disorder Hazardous Substances DB METHYLPHENIDATE Social Bookmarking                         What's this?

Methylphenidate Protocol: Feasibility in a Pediatric Practice

1835 Oakland Avenue, Portsmouth, Ohio 45662

This report examines the feasibility of double blind individual trials of methylphenidate versus placebo in a general pediatric practice to assess benefit of this medication in the treatment of attention deficit disorder.

Children presenting with the diagnosis of attention deficit disorder were enrolled in a three-week protocol. The first week was a baseline week during which teachers and parents completed the Connors rating scales. During the second and third weeks of each trial, placebo or methylphenidate was given for a week each in an unknown order to parents, teachers or the investigator. Respective Connors rating scales were also completed for each of these weeks. At the end of the third week, the three parent questionnaires and the three teacher questionnaires were returned to the investigator for scoring and disclosure about findings.

During a pilot period, 53% of the trials were improperly completed. Reasons for this were addressed and with simple measures the rate of successful completion was raised to 83%. During the study phase, 43% of the children were found to be hyperactive but they did not benefit from medication. In six trials there was disagreement between teachers and parents. The completed trials and many of the incompleted trials were helpful in the assessment of the children with attention deficit disorder and their response to medication. It is felt that this approach is suitable for a private general pediatric practice.

Clinical Pediatrics, Vol. 30, No. 12, 656-660 (1991)
DOI: 10.1177/000992289103001201


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. L. Wodrich and S. Landau School Psychologists: Strategic Allies in the Contemporary Practice of Primary Care Pediatrics Clinical Pediatrics, October 1, 1999; 38(10): 597 - 606. [Abstract] [PDF]

				J. B. Hale, J.-A. B. Hoeppner, M. B. DeWitt, D. L. Coury, D. G. Ritacco, and B. Trommer Evaluating Medication Response in ADHD: Cognitive, Behavioral, and Single-Subject Methodology J Learn Disabil, November 1, 1998; 31(6): 595 - 607. [Abstract] [PDF]

				J.B. Hoeppner, J.B. Hale, A.M. Bradley, M. Byrnes, D.L. Coury, L. Lennie, and B.L. Trommer A clinical protocol for determining methylphenidate dosage levels in ADHD J Atten Disord, April 1, 1997; 2(1): 19 - 30. [Abstract]

				D. C. Vinson Therapy for Attention-Deficit Hyperactivity Disorder Arch Fam Med, May 1, 1994; 3(5): 445 - 451. [Abstract] [PDF]

				J. C. Langer, A. L. Winthrop, and R. M. Issenman The Single-Subject Randomized Trial: A Useful Clinical Tool for Assessing Therapeutic Efficacy in Pediatric Practice Clinical Pediatrics, November 1, 1993; 32(11): 654 - 657. [Abstract] [PDF]

				J. M. Farber Methylphenidate Protocol: Feasibility in a Pediatric Practice Clinical Pediatrics, August 1, 1993; 32(8): 508 - 509. [PDF]